ClinicalTrials.gov · NCT06975111 · Recruiting
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Registry record
NCT06975111 on ClinicalTrials.gov. The registry's last update to this record was 4 November 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Focusing on the Menopausal Transition to Improve Mid-Life Women's Health Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor University of Colorado, Denver Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Metformin; semaglutide; Anti-hypertensives; Lipid Lowering Medication; Life style intervention; Fezolinetant; Hormonal therapy Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Epigenetic aging measurements of "PhenoAge" | Epigenetic aging measurements of "GrimAge" Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-11-04. Checked
Check history: NCT06975111 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: University of Colorado, Denver
- Phase: Phase 2, Phase 3
- Status: Recruiting
- Intervention: Metformin; semaglutide; Anti-hypertensives; Lipid Lowering Medication; Life style intervention; Fezolinetant; Hormonal therapy
- Primary outcome: Epigenetic aging measurements of "PhenoAge" | Epigenetic aging measurements of "GrimAge"
- Countries: United States
- Start: 1 March 2026
- Completion (estimated): 1 October 2030
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.